Travere Therapeutics (TVTX)
(Real Time Quote from BATS)
$6.78 USD
-0.04 (-0.59%)
Updated May 9, 2024 02:07 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Travere Therapeutics, Inc. [TVTX]
Reports for Purchase
Showing records 101 - 120 ( 126 total )
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Vifor Takes the Reigns In Europe - Sparsentan Commercialization Agreement
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
FDA, TVTX Agree on Path Forward For FSGS/Sparsentan
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
PROTECTing The Sparsentan Franchise - PROTECT Meets Primary Endpoint
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Downgrading to Neutral; Arguing Balls and Strikes Won''t Change the Outcome
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Selloff Overdone In Our View - Continue To Hold Positive Bias
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Pushing Forward Towards PROTECT - Next Readout On Track For 3Q21
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
1Q21 Commercial Biotech Preview: Are We In A Bear Market?
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Delving More Into DUPLEX - Raising Target to $46 on TVTX
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Travere Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
With Most Of The Fireworks Already Shot Off, Looking For Quiet 4Q20 Reporting
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L